查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573045

植物來源藥物市場：按類型、來源、治療應用、配方、最終用戶、給藥途徑- 2025-2030 年全球預測

Botanical Drug Market by Type (Herbal Drugs, Nutraceuticals, Phytomedicines), Source (Algae, Fungi, Plants), Therapeutic Application, Formulation, End User, Route Of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年植物來源市值為37.5億美元，預計到2024年將達到40.1億美元，複合年成長率為6.96%，到2030年預計將達到60.1億美元。

植物藥物被定義為植物來源的複雜混合物，由於其天然來源和治療潛力而越來越受歡迎。這些藥物包括各種形式，如酊劑、茶和精油，特別注重標準化具有藥用特性的萃取物。消費者對天然和永續醫療保健選擇的日益偏好以及全球監管機構的日益接受推動了對植物藥的需求。植物藥物主要用於治療關節炎、心血管疾病和癌症等慢性疾病，這些疾病的傳統治療方法很難或有顯著的副作用。最終用途範圍包括製藥、食品和個人護理行業，受益於人們對傳統醫學和整體健康日益成長的興趣。根據市場洞察，關鍵的成長要素包括研發投資的活性化、有利的法規以及公眾對植物來源健康解決方案的認知不斷提高。最新的商機是將植物療法的應用擴展到個人化和整合醫學。利用這些機會的研究包括培養策略研究夥伴關係、最佳化永續採購的供應鏈以及參與公共衛生教育。然而，它們也有局限性，包括複雜的法律規範、與合成物相比有限的臨床資料，以及由於自然變異而保持產品一致性的挑戰。此外，供應鏈中斷和嚴格的專利法可能會阻礙市場成長。最佳創新領域包括改進萃取方法、開發標準化配方以及利用生物技術的進步來提高植物藥物的治療功效和安全性。由於市場分散，中小企業眾多，因此有充分的機會透過有針對性的創新和敏捷的業務策略來建立利基領導地位。了解消費者趨勢和投資可擴展的基礎設施對於駕馭植物醫學的複雜格局至關重要，而跟上不斷變化的監管格局對於提高競爭力至關重要。

主要市場統計
基準年[2023] 37.5億美元
預測年份 [2024] 40.1億美元
預測年份 [2030] 60.1億美元
複合年成長率（%） 6.96%

市場動態：揭示快速發展的植物來源藥物市場的關鍵市場洞察

植物來源市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 支持植物藥發展的政府措施和資金
    • 拓展植物產品通路與電商平台
    • 在植物來源藥物生產中採用先進的萃取和配方技術
    • 主要市場參與者對植物來源藥物研究和商業化進行了大量投資
  • 市場限制因素
    • 關於植物藥功效和安全性的臨床試驗資料和科學檢驗有限
    • 智慧財產權挑戰和合成藥物的競爭阻礙了市場成長
  • 市場機會
    • 慢性病盛行率的增加增加了植物藥物替代治療的採用
    • 透過擴大分銷管道（包括電子商務平台）來提高市場覆蓋率和可及性
    • 開拓滿足個人健康需求和偏好的個人化植物藥市場將推動市場成長
  • 市場挑戰
    • 支持植物來源藥物功效和安全性主張的科學證據和臨床試驗有限，阻礙了市場成長
    • 供應鏈中斷和原料短缺影響植物來源製藥業的生產一致性

波特五力：駕馭植物來源藥物市場的策略工具

波特的五力架構是了解植物來源市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解植物來源醫藥市場的外部影響

外部宏觀環境因素在塑造植物來源市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解植物來源市場的競爭狀況

對植物來源藥物市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣植物來源藥品市場供應商的績效評估

FPNV定位矩陣是評估植物來源市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了植物來源市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對植物來源市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 支持植物藥發展的政府措施和資金
      • 擴大植物來源產品的通路與電子商務平台
      • 在植物來源藥物生產中採用先進的萃取和複合技術
      • 主要市場參與者對植物來源藥物的研究和商業化進行了大量投資
    • 抑制因素
      • 植物藥功效和安全性的臨床試驗資料和科學檢驗有限。
      • 智慧財產權挑戰和合成藥物的競爭阻礙了市場成長
    • 機會
      • 慢性病盛行率上升增加了植物藥物替代療法的採用
      • 擴大分銷管道，包括電子商務平台，擴大市場覆蓋範圍和可及性
      • 根據個人健康需求和偏好開發個人化植物藥物將推動市場成長
    • 任務
      • 支持功效和安全性主張的科學證據和臨床試驗有限，阻礙了市場成長
      • 供應鏈中斷和原料短缺影響植物來源製藥業的生產一致性
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章植物來源藥物市場：依類型

  • 草藥
    • 多種草藥
    • 單一草藥
  • 食品補充品
  • 植物藥

第7章植物來源藥物市場：依來源分類

  • 藻類
  • 真菌
  • 植物
    • 吠
    • 葉子
    • 根
    • 種子

第8章植物來源

  • 癌症
  • 心血管疾病
  • 糖尿病
  • 消化系統疾病
  • 呼吸系統疾病

第9章植物來源藥物處方市場

  • 膠囊
  • 摘抄
  • 軟膏
  • 粉末
  • 藥片

第10章植物來源藥物市場：依最終用戶分類

  • 診所
  • 居家護理
  • 醫院

第11章植物來源藥物市場：依給藥途徑

  • 可注射的
  • 口服
  • 話題

第12章美洲植物來源市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章亞太植物來源市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第14章歐洲、中東和非洲植物來源藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C04EA

The Botanical Drug Market was valued at USD 3.75 billion in 2023, expected to reach USD 4.01 billion in 2024, and is projected to grow at a CAGR of 6.96%, to USD 6.01 billion by 2030.

Botanical drugs, defined as complex mixtures derived from plant-based sources, have been gaining traction due to their natural origin and therapeutic potential. These drugs encompass various forms, including tinctures, teas, and essential oils, focusing especially on standardizing extracts with medicinal properties. The necessity for botanical drugs stems from the rising consumer preference for natural, sustainable healthcare options coupled with increased acceptance by global regulatory bodies. They are primarily applied in treating chronic diseases, such as arthritis, cardiovascular ailments, and cancer, where conventional treatments may falter or present significant side effects. The scope of end-use includes pharmaceutical, nutraceutical, and personal care industries, benefitting from growing interests in traditional medicine and holistic health. Market insights reveal that key growth factors include heightened R&D investments, favorable regulations, and increased public awareness of plant-based health solutions. Latest opportunities lie in personalizing botanical therapies and expanding applications in integrative medicine practices. Recommendations to capitalize on these opportunities include fostering strategic partnerships for research, optimizing supply chains for sustainable sourcing, and engaging in public health education. However, limitations include complex regulatory frameworks, limited clinical data compared to synthetics, and challenges in maintaining product consistency due to natural variability. Additionally, supply chain disruptions and stringent patent laws can hinder market growth. The best areas for innovation involve improving extraction methods, developing standardized formulations, and leveraging biotechnological advancements to enhance therapeutic efficacy and safety profiles of botanical drugs. As the market is characterized by fragmentation with numerous small to mid-sized firms, opportunities abound for establishing niche leadership through targeted innovations and agile business strategies. Understanding consumer trends and investing in a scalable infrastructure is crucial for navigating the complex landscape of botanical drugs, while staying abreast of evolving regulatory standards can provide a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 3.75 billion
Estimated Year [2024] USD 4.01 billion
Forecast Year [2030] USD 6.01 billion
CAGR (%) 6.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Botanical Drug Market

The Botanical Drug Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and funding supporting the development of botanical drugs
    • Expansion of distribution channels and e-commerce platforms for botanical products
    • Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
    • Significant investments by key market players in botanical drug research and commercialization
  • Market Restraints
    • Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
    • Intellectual property challenges and competition with synthetic drugs impede market growth
  • Market Opportunities
    • Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
    • Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
    • Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
  • Market Challenges
    • Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
    • Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry

Porter's Five Forces: A Strategic Tool for Navigating the Botanical Drug Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Botanical Drug Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Botanical Drug Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Botanical Drug Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Botanical Drug Market

A detailed market share analysis in the Botanical Drug Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Botanical Drug Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Botanical Drug Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Botanical Drug Market

A strategic analysis of the Botanical Drug Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Botanical Drug Market, highlighting leading vendors and their innovative profiles. These include Aphios Corporation, Botanix Pharmaceuticals Ltd, CanniMed Therapeutics Inc., Cardiol Therapeutics Inc., CV Sciences, Inc., Ecofibre Limited, EcoGen Laboratories, Emerald Health Pharmaceuticals, GB Sciences, Inc., GW Pharmaceuticals plc, HempMeds, InMed Pharmaceuticals Inc., Jazz Pharmaceuticals plc, Lexaria Bioscience Corp., MediPharm Labs Corp., PhytoTech Therapeutics Ltd., Tetra Bio-Pharma Inc., Tikun Olam Ltd., Veritas Pharma Inc., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Botanical Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Herbal Drugs, Nutraceuticals, and Phytomedicines. The Herbal Drugs is further studied across Multiple Herb Drugs and Single Herb Drugs.
  • Based on Source, market is studied across Algae, Fungi, and Plants. The Plants is further studied across Barks, Leaves, Roots, and Seeds.
  • Based on Therapeutic Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Digestive Disorders, and Respiratory Disorders.
  • Based on Formulation, market is studied across Capsules, Extracts, Ointments, Powders, and Tablets.
  • Based on End User, market is studied across Clinics, Homecare, and Hospitals.
  • Based on Route Of Administration, market is studied across Injectable, Oral, and Topical.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and funding supporting the development of botanical drugs
      • 5.1.1.2. Expansion of distribution channels and e-commerce platforms for botanical products
      • 5.1.1.3. Adoption of advanced extraction and formulation technologies in botanical drug manufacturing
      • 5.1.1.4. Significant investments by key market players in botanical drug research and commercialization
    • 5.1.2. Restraints
      • 5.1.2.1. Limited clinical trial data and scientific validation on the efficacy and safety of botanical drugs
      • 5.1.2.2. Intellectual property challenges and competition with synthetic drugs impede market growth
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising prevalence of chronic diseases increasing the adoption of botanical drugs for alternative treatment
      • 5.1.3.2. Expansion of distribution channels including e-commerce platforms boosting market reach and accessibility
      • 5.1.3.3. Development of personalized botanical medicine catering to individual health needs and preferences driving market growth
    • 5.1.4. Challenges
      • 5.1.4.1. Limited scientific evidence and clinical trials to support botanical drug efficacy and safety claims hamper market growth
      • 5.1.4.2. Supply chain disruptions and raw material scarcity affect production consistency in the botanical drug industry
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Botanical Drug Market, by Type

  • 6.1. Introduction
  • 6.2. Herbal Drugs
    • 6.2.1. Multiple Herb Drugs
    • 6.2.2. Single Herb Drugs
  • 6.3. Nutraceuticals
  • 6.4. Phytomedicines

7. Botanical Drug Market, by Source

  • 7.1. Introduction
  • 7.2. Algae
  • 7.3. Fungi
  • 7.4. Plants
    • 7.4.1. Barks
    • 7.4.2. Leaves
    • 7.4.3. Roots
    • 7.4.4. Seeds

8. Botanical Drug Market, by Therapeutic Application

  • 8.1. Introduction
  • 8.2. Cancer
  • 8.3. Cardiovascular Diseases
  • 8.4. Diabetes
  • 8.5. Digestive Disorders
  • 8.6. Respiratory Disorders

9. Botanical Drug Market, by Formulation

  • 9.1. Introduction
  • 9.2. Capsules
  • 9.3. Extracts
  • 9.4. Ointments
  • 9.5. Powders
  • 9.6. Tablets

10. Botanical Drug Market, by End User

  • 10.1. Introduction
  • 10.2. Clinics
  • 10.3. Homecare
  • 10.4. Hospitals

11. Botanical Drug Market, by Route Of Administration

  • 11.1. Introduction
  • 11.2. Injectable
  • 11.3. Oral
  • 11.4. Topical

12. Americas Botanical Drug Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Botanical Drug Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Botanical Drug Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aphios Corporation
  • 2. Botanix Pharmaceuticals Ltd
  • 3. CanniMed Therapeutics Inc.
  • 4. Cardiol Therapeutics Inc.
  • 5. CV Sciences, Inc.
  • 6. Ecofibre Limited
  • 7. EcoGen Laboratories
  • 8. Emerald Health Pharmaceuticals
  • 9. GB Sciences, Inc.
  • 10. GW Pharmaceuticals plc
  • 11. HempMeds
  • 12. InMed Pharmaceuticals Inc.
  • 13. Jazz Pharmaceuticals plc
  • 14. Lexaria Bioscience Corp.
  • 15. MediPharm Labs Corp.
  • 16. PhytoTech Therapeutics Ltd.
  • 17. Tetra Bio-Pharma Inc.
  • 18. Tikun Olam Ltd.
  • 19. Veritas Pharma Inc.
  • 20. Zynerba Pharmaceuticals, Inc.

LIST OF FIGURES

  • FIGURE 1. BOTANICAL DRUG MARKET RESEARCH PROCESS
  • FIGURE 2. BOTANICAL DRUG MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. BOTANICAL DRUG MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. BOTANICAL DRUG MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BOTANICAL DRUG MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BOTANICAL DRUG MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BOTANICAL DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BOTANICAL DRUG MARKET DYNAMICS
  • TABLE 7. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BOTANICAL DRUG MARKET SIZE, BY MULTIPLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SINGLE HERB DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BOTANICAL DRUG MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PHYTOMEDICINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FUNGI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BOTANICAL DRUG MARKET SIZE, BY BARKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BOTANICAL DRUG MARKET SIZE, BY LEAVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BOTANICAL DRUG MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BOTANICAL DRUG MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BOTANICAL DRUG MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BOTANICAL DRUG MARKET SIZE, BY EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BOTANICAL DRUG MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BOTANICAL DRUG MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BOTANICAL DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL BOTANICAL DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL BOTANICAL DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL BOTANICAL DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL BOTANICAL DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES BOTANICAL DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 112. CHINA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. CHINA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. INDIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. INDIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. INDIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 122. INDIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. INDONESIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDONESIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 128. INDONESIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. INDONESIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 130. INDONESIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDONESIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. JAPAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. JAPAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 136. JAPAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. JAPAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 138. JAPAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. JAPAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 140. JAPAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 144. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 146. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 148. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. MALAYSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 150. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 152. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 154. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 156. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. PHILIPPINES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 162. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SINGAPORE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH KOREA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. TAIWAN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TAIWAN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. TAIWAN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. TAIWAN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 178. TAIWAN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TAIWAN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 180. TAIWAN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. TAIWAN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. THAILAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. THAILAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. THAILAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. THAILAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 186. THAILAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. THAILAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. THAILAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. THAILAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. VIETNAM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. VIETNAM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 192. VIETNAM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 193. VIETNAM BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 194. VIETNAM BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. VIETNAM BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 196. VIETNAM BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. VIETNAM BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BOTANICAL DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 207. DENMARK BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. DENMARK BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 209. DENMARK BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 210. DENMARK BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 211. DENMARK BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. DENMARK BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 213. DENMARK BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. DENMARK BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 215. EGYPT BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. EGYPT BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 217. EGYPT BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 218. EGYPT BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 219. EGYPT BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. EGYPT BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 221. EGYPT BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. EGYPT BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. FINLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. FINLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 225. FINLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 226. FINLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 227. FINLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. FINLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 229. FINLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. FINLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 231. FRANCE BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. FRANCE BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. FRANCE BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 234. FRANCE BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 235. FRANCE BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. FRANCE BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 237. FRANCE BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. FRANCE BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. GERMANY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. GERMANY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 241. GERMANY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 242. GERMANY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 243. GERMANY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. GERMANY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 245. GERMANY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. GERMANY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 247. ISRAEL BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. ISRAEL BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 249. ISRAEL BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 250. ISRAEL BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 251. ISRAEL BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. ISRAEL BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 253. ISRAEL BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. ISRAEL BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. ITALY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. ITALY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 257. ITALY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 258. ITALY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 259. ITALY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. ITALY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 261. ITALY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 262. ITALY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 266. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. NETHERLANDS BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 271. NIGERIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. NIGERIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 273. NIGERIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 274. NIGERIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 275. NIGERIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. NIGERIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 277. NIGERIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. NIGERIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. NORWAY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. NORWAY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 281. NORWAY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 282. NORWAY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 283. NORWAY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. NORWAY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 285. NORWAY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. NORWAY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 287. POLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. POLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. POLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 290. POLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 291. POLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. POLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 293. POLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. POLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. QATAR BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. QATAR BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 297. QATAR BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 298. QATAR BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 299. QATAR BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. QATAR BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 301. QATAR BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. QATAR BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 303. RUSSIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. RUSSIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 305. RUSSIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 306. RUSSIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 307. RUSSIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. RUSSIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 309. RUSSIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 310. RUSSIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 312. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 314. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 316. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. SAUDI ARABIA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 322. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 324. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 326. SOUTH AFRICA BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 327. SPAIN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 328. SPAIN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 329. SPAIN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 330. SPAIN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 331. SPAIN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 332. SPAIN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 333. SPAIN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 334. SPAIN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 335. SWEDEN BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SWEDEN BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 337. SWEDEN BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 338. SWEDEN BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 339. SWEDEN BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 340. SWEDEN BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 341. SWEDEN BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. SWEDEN BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 346. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 350. SWITZERLAND BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 351. TURKEY BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 352. TURKEY BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 353. TURKEY BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 354. TURKEY BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 355. TURKEY BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 356. TURKEY BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 357. TURKEY BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 358. TURKEY BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY PLANTS, 2018-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 366. UNITED ARAB EMIRATES BOTANICAL DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 367. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 368. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY HERBAL DRUGS, 2018-2030 (USD MILLION)
  • TABLE 369. UNITED KINGDOM BOTANICAL DRUG MARKET SIZE, BY SOURCE, 201